Chiodera P, Volpi R, Capretti L, Coiro V. Oxytocin enhances the prolactin response to vasoactive intestinal polypeptide in healthy women.
Fertil Steril 1998;
70:541-3. [PMID:
9757887 DOI:
10.1016/s0015-0282(98)00202-7]
[Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
OBJECTIVE
To establish whether oxytocin modifies the stimulatory effect of vasoactive intestinal polypeptide (VIP) on prolactin secretion in healthy women.
DESIGN
Controlled clinical study.
SETTING
Healthy women in an academic research environment.
PATIENT(S)
Seven healthy women (aged 24-32 years) were tested on the 22nd day of two consecutive normal menstrual cycles.
INTERVENTION(S)
Vasoactive intestinal polypeptide (4 pmol x kg(-1) x min(-1) in 50 mL of normal saline infused i.v. for 60 minutes) was administered in either the presence or absence of concurrent treatment with oxytocin (2 IU injected plus 0.07 IU/min infused for 60 minutes).
MAIN OUTCOME MEASURE(S)
Serum prolactin levels.
RESULT(S)
The administration of VIP induced a significant increase in serum prolactin levels, with a mean peak response 1.6 times higher than baseline at 45 minutes after injection. In the presence of oxytocin, the prolactin response to VIP was significantly higher, with a mean peak response 2 times higher than baseline.
CONCLUSION(S)
These data suggest that in healthy women, oxytocin facilitates the regulation of the stimulating effect of VIP on prolactin secretion.
Collapse